This interesting study tests a combination of drugs for poorly controlled type 2 diabetics. The outcome: lower A1c by 1% and 1/3 the rate of hypoglycemia compared to insulin!
Check this out:
To be clear: this study specifically targeted poorly controlled T2Ds – not the general T2D population.